Wen Jiang

20.9k total citations · 6 hit papers
269 papers, 11.0k citations indexed

About

Wen Jiang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wen Jiang has authored 269 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 58 papers in Oncology and 46 papers in Immunology. Recurrent topics in Wen Jiang's work include Cancer Immunotherapy and Biomarkers (31 papers), Nanoparticle-Based Drug Delivery (28 papers) and Immunotherapy and Immune Responses (25 papers). Wen Jiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (31 papers), Nanoparticle-Based Drug Delivery (28 papers) and Immunotherapy and Immune Responses (25 papers). Wen Jiang collaborates with scholars based in China, United States and Canada. Wen Jiang's co-authors include Betty Y.S. Kim, Irving L. Weissman, Yifan Wang, Charles K. F. Chan, Warren C. W. Chan, Yuhui Huang, Yao Wu, Zhongwei Gu, Christina A. Von Roemeling and Cheng Cheng Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Wen Jiang

255 papers receiving 10.9k citations

Hit Papers

Multistage nanoparticle delivery system for deep penetrat... 2011 2026 2016 2021 2011 2019 2018 2021 2022 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multistage nanoparticle delivery system for deep penetration into tumor tissue
    2011 895 citations Wen Jiang et al. profile →
  2. Phagocytosis checkpoints as new targets for cancer immunotherapy
    2019 689 citations Wen Jiang, Betty Y.S. Kim et al. profile →
  3. Improving immune–vascular crosstalk for cancer immunotherapy
    2018 420 citations Betty Y.S. Kim, Charles K. F. Chan et al. profile →
  4. Statins: a repurposed drug to fight cancer
    2021 269 citations Wen Jiang et al. profile →
  5. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
    2022 245 citations Nourhan Abdelfattah, Parveen Kumar et al. Nature Communications profile →
  6. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles
    2022 151 citations Yifan Wang, Kristin Huntoon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Jiang China 55 3.3k 3.2k 2.7k 2.4k 2.3k 269 11.0k
Zhi‐Jun Sun China 59 4.3k 1.3× 5.4k 1.7× 3.4k 1.3× 3.4k 1.4× 1.8k 0.8× 311 12.6k
Heike E. Daldrup‐Link United States 56 3.2k 1.0× 2.2k 0.7× 1.3k 0.5× 1.4k 0.6× 2.0k 0.9× 242 10.5k
Zheng Wang China 70 3.7k 1.1× 7.6k 2.3× 2.6k 1.0× 2.3k 1.0× 2.8k 1.2× 633 19.2k
Na Zhang China 57 3.0k 0.9× 4.9k 1.5× 1.6k 0.6× 1.8k 0.7× 3.0k 1.3× 460 12.2k
Baorui Liu China 47 2.0k 0.6× 3.6k 1.1× 2.7k 1.0× 1.5k 0.6× 1.4k 0.6× 379 8.7k
Pat Zanzonico United States 56 2.3k 0.7× 2.9k 0.9× 2.2k 0.8× 670 0.3× 1.3k 0.6× 269 11.6k
Hai Wang China 49 2.8k 0.9× 3.8k 1.2× 1.8k 0.7× 651 0.3× 2.1k 0.9× 249 9.6k
Zhiping Zhang China 48 2.9k 0.9× 4.2k 1.3× 1.0k 0.4× 1.1k 0.4× 3.2k 1.4× 168 9.7k
Hongbo Zhang China 71 7.1k 2.2× 6.0k 1.9× 1.2k 0.4× 1.3k 0.5× 3.6k 1.6× 507 18.4k
William M. Gallagher Ireland 61 2.8k 0.9× 6.8k 2.1× 4.0k 1.5× 2.4k 1.0× 715 0.3× 257 15.6k

Countries citing papers authored by Wen Jiang

Since Specialization
Citations

This map shows the geographic impact of Wen Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Jiang more than expected).

Fields of papers citing papers by Wen Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Jiang. The network helps show where Wen Jiang may publish in the future.

Co-authorship network of co-authors of Wen Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Jiang. A scholar is included among the top collaborators of Wen Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Jiang. Wen Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Shuai, Duo Gao, Yiming Xu, et al.. (2024). Maternal gastrointestinal microbiome shapes gut microbial function and resistome of newborns in a cow-to-calf model. Microbiome. 12(1). 216–216. 9 indexed citations
4.
5.
Wang, Ting, et al.. (2023). Determination of nine cardiovascular drugs in human plasma by QuEChERS-UPLC-MS/MS. Heliyon. 9(12). e22543–e22543. 2 indexed citations
6.
Yeboa, D.N., Sujit S. Prabhu, J. Li, et al.. (2023). MD Anderson Phase III Randomized Preoperative Stereotactic Radiosurgery (SRS) vs. Postoperative SRS for Brain Metastases Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). e160–e161. 2 indexed citations
7.
8.
Jiang, Wen, Tingting Qiao, Xiaqing Yu, et al.. (2023). Integrated microbiome and metabolome analysis reveals a distinct microbial and metabolic signature in Graves' disease and hypothyroidism. Heliyon. 9(11). e21463–e21463. 2 indexed citations
9.
Huntoon, Kristin, et al.. (2023). Targeting phagocytosis to enhance antitumor immunity. Trends in cancer. 9(8). 650–665. 9 indexed citations
10.
George, Joshy, Yaohui Chen, Nourhan Abdelfattah, et al.. (2022). Cancer Stem Cells, not Bulk Tumor Cells, Determine Mechanisms of Resistance to SMO Inhibitors. Cancer Research Communications. 2(6). 402–416. 5 indexed citations
11.
Li, Jun, Chao Xue, Hao Wang, et al.. (2022). Hybrid Nanofibrous Composites with Anisotropic Mechanics and Architecture for Tendon/Ligament Repair and Regeneration. Small. 18(27). e2201147–e2201147. 19 indexed citations
12.
Wang, Yifan, Yaqing Qie, Hengfeng Yuan, et al.. (2020). Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nature Communications. 11(1). 1508–1508. 187 indexed citations
13.
Xi, Yongzhi, Tong Jiang, Ning Xu, et al.. (2019). Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Chen, Yuanxin, Xiujie Liu, Hengfeng Yuan, et al.. (2019). Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery. Advanced Science. 6(5). 103 indexed citations
15.
Sun, Yating, Robert J. Lee, Guiyuan Wang, et al.. (2019). Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel. Cancers. 11(10). 1571–1571. 36 indexed citations
16.
Li, Qian, Yifan Wang, Weijuan Jia, et al.. (2019). Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade. Clinical Cancer Research. 26(7). 1712–1724. 116 indexed citations
17.
Wang, Yifan, Nan Li, Wen Jiang, et al.. (2018). Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(22). 5744–5756. 30 indexed citations
18.
Park, Hee Jung, Joshy George, Keiko Yamamoto, et al.. (2017). S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. Cancer Research. 77(19). 5360–5373. 92 indexed citations
19.
Wang, Yifan, Jayanthi Gudikote, Uma Giri, et al.. (2017). RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer. Clinical Cancer Research. 24(2). 341–350. 32 indexed citations
20.
Jiang, Wen, Rajayogesh Davuluri, Penny Fang, et al.. (2016). Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response. International Journal of Radiation Oncology*Biology*Physics. 96(2). S151–S151. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Jun Sun Breakdown of academic impact, for papers by Heike E. Daldrup‐Link Breakdown of academic impact, for papers by Zheng Wang Breakdown of academic impact, for papers by Na Zhang Breakdown of academic impact, for papers by Baorui Liu Breakdown of academic impact, for papers by Pat Zanzonico Breakdown of academic impact, for papers by Hai Wang Breakdown of academic impact, for papers by Zhiping Zhang Breakdown of academic impact, for papers by Hongbo Zhang Breakdown of academic impact, for papers by William M. Gallagher
Rankless by CCL
2026